Heart rhythm care at Cedars-Sinai has new leadership. Michael M. Shehata, MD, will direct the Division of Cardiac Electrophysiology, bringing a research record in leadless pacemakers, pulsed field ablation and artificial intelligence for personalized care. Read more: https://ceda.rs/4ftxNxa

More than 51,000 learner interactions run through Cedars-Sinai Continuing Medical Education each year, spanning live conferences, grand rounds and on-demand courses for healthcare professionals across disciplines. Learn more: https://ceda.rs/3TCuFYP

Machine learning is helping Cedars-Sinai investigators read the warning signs before a sudden cardiac arrest. Shortness of breath in people with coronary artery disease or heart failure stood out, & those symptoms usually appeared at least 15 minutes in advance. Learn more: https://ceda.rs/4fxZUN5

Care for opioid use disorder often breaks down after discharge. New Cedars-Sinai co-led research found that patients who worked with a hospital addiction team were more likely to stay connected to follow-up treatment once they went home. Learn more: https://ceda.rs/3TpOSkl

Cedars-Sinai joined Biotech Connection Los Angeles at the Pacific Design Center for Debugging Your Biotech Career, an evening on AI, computational biology and the people building the industry across Los Angeles. Nimisha Mazumdar and Haley Jun shared their takeaways.

Mia E. Miller, MD, is the new director of Otolaryngology–Head and Neck Surgery at Cedars-Sinai. An early priority is developing a hearing regeneration lab, and she has hired Cedars-Sinai's first otolaryngology PhD researcher to help lead it. Read more about her appointment: https://ceda.rs/3SYubfj

Good mentorship keeps moving. Gideon Blumstein, MD, trained under spine surgeon David Skaggs, MD, at Cedars-Sinai Health Sciences University and now teaches endoscopy courses and walks younger surgeons through their first cases. Read more: https://ceda.rs/3TeW42Q

Heart cells first isolated at Cedars-Sinai in 2004 are now behind a Phase III therapy for Duchenne muscular dystrophy. Deramiocel slowed the progression of heart failure and the loss of upper limb function in boys and young men, according to new results in The Lancet. https://ceda.rs/4pMBCT7

Why do platelet-rich plasma injections ease knee arthritis for some patients and not others? A new Cedars-Sinai Health Sciences University study looks inside each patient's injection for an early answer. Read more: https://ceda.rs/3TpOSkl

As AI enters medical decision-making, Rabbi Dr. Jason Weiner, BCC, of Cedars-Sinai makes the case for keeping human values at the center of care. His new work brings religious and ethical thought to questions in AI and end-of-life care. Read more: https://ceda.rs/4adRdoi

About 1 in 5 people with unexplained spinal cerebrospinal fluid leaks carry changes in a single gene, FBN2, new Cedars-Sinai Health Sciences University research with a partner university shows. The finding could point toward earlier diagnosis and targeted treatment. https://ceda.rs/4wIOls7

Mentorship is central to advancing stroke science. At Cedars-Sinai, Director of Stroke Research Alexis Simpkins, MD, PhD, pairs scientific independence with intentional mentorship to train the next generation of investigators while pushing stroke research forward. Read more: https://ceda.rs/3TffS64

A new Cedars-Sinai Health Sciences University study found that hepatitis C-positive donor organs shortened the pancreas transplant wait by an average of 117 days with comparable safety. Antivirals that cure hepatitis C make wider use of these organs possible. Read more: https://ceda.rs/3PzX1kR

After being diagnosed with breast cancer, Gaby M. chose to participate in a clinical trial in search of another path forward. Supported by her care team every step of the way, she felt empowered with the opportunity to help advance cancer care for future patients. ❤️

In younger people, sudden cardiac arrest is more often driven by a genetic cause. New research from the Smidt Heart Institute at Cedars-Sinai points to broader genetic testing as a way to identify risk earlier. Learn more: https://ceda.rs/3SniVZy

Life at Cedars-Sinai extends beyond residency and fellowship. 🌴 Whether it's trying a new hobby, exploring Los Angeles or spending time with friends after a busy week, our residents and fellows find community, connection and opportunities to make LA feel like home. More: https://ceda.rs/44CmRZQ

An oral medication called daraxonrasib doubled survival in patients with advanced pancreatic cancer in a Phase III trial published in The New England Journal of Medicine. Read more in this Q&A with Dr. Andrew Hendifar: https://ceda.rs/4wcyH8o

Cedars-Sinai's collaborations with Israeli institutions reach from the operating room to the International Space Station, advancing heart care, digital health and stem cell science. Read more: https://ceda.rs/4vokg0p

Cedars-Sinai investigators have identified molecular pathways that drive inflammation and scarring in alcohol-associated liver disease, a condition that causes nearly half of liver-disease-related deaths in the U.S. and still has no effective treatment. Learn more: https://ceda.rs/4vaBazf

New Cedars-Sinai research links hypothyroidism to a higher risk of small intestinal bacterial overgrowth, adding insight into how gut bacteria shape health beyond digestion. Learn more: https://ceda.rs/4p1Ovsd

Cedars-Sinai care teams now have a new AI tool that brings the latest medical evidence into the context of each patient's own record, helping inform diagnosis and treatment at the moment of care. Learn more: https://ceda.rs/43GGHSB

Cedars-Sinai investigators developed a hospital screening method that catches undiagnosed cognitive impairment and dementia in older adults at admission, giving care teams more time to plan safer stays and discharge. Learn more: https://ceda.rs/3PzX1kR

Every patient is someone’s family. Internal medicine resident Cymac “Mac” Heravian, MD shares how mentorship, teamwork and a culture of service shape residency training at Cedars-Sinai.

Mapping gene activity across a tumor can take weeks and cost thousands of dollars. Cedars-Sinai-led investigators built Path2Space to do it from existing biopsy slides in minutes, for far less. With more testing, it could help bring personalized cancer care to more people. https://ceda.rs/4vb7DpI

A BRCA mutation can mean up to a dozen separate cancer screenings, each its own appointment. The new Cedars-Sinai Cayton BRCA Center, opening in early July, brings them into a single coordinated visit. Learn more: https://ceda.rs/4w326l2

New early-stage Cedars-Sinai research tested a dialysis-like treatment that filters sFlt-1, a placental protein driving preeclampsia, lengthening pregnancy by about 10 days in a small study. The approach is experimental and needs larger trials. Learn more: https://ceda.rs/4t7a6Qi

Cedars-Sinai investigators are joining a $9 million multi-institutional effort to clarify how pesticide exposure and genetics drive Parkinson's disease, using lab-grown neurons from affected families to study the biology behind the condition. Learn more: https://ceda.rs/4ouv76C 🔬

Transcatheter tricuspid valve replacement delivered strong early outcomes in real-world care, with meaningful improvement in symptoms and quality of life within 30 days. Learn more about the national study was led by Cedars-Sinai investigators: https://ceda.rs/4v9kY1J

Congratulations to the Cedars-Sinai Health Sciences University Class of 2026. Graduates of the Graduate School of Biomedical Sciences & the inaugural class of the Chuck Lorre School of Allied Health carry their compassion, skill & resilience into careers that strengthen patient care and communities.

The American Academy of Arts and Sciences has honored Cedars-Sinai president and CEO emeritus Thomas M. Priselac for more than three decades of nonprofit leadership. Learn more: https://ceda.rs/4difqub